Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

This study was designed to characterize failure-free survival (FFS) as a novel end point for clinical trials of chronic graft-versus-host disease (GVHD). The study cohort included 400 consecutive patients who received initial systemic treatment of chronic GVHD at our center. FFS was defined by the a...

Full description

Saved in:
Bibliographic Details
Main Authors: Inamoto, Yoshihiro, Flowers, Mary E. D., Sandmaier, Brenda M., Aki, Sahika Z., Carpenter, Paul A., Lee, Stephanie J., Storer, Barry E., Martin, Paul J.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2014
Subjects:
Transplantation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141518/
https://ncbi.nlm.nih.gov/pubmed/24876566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563544
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items